Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 713 results found. Search for [ Indian pharma companies in US ]

Results 1 to 21 of 713
BusinessToday.In
May 21, 2019
Share Market Update: Market Breadth was in favour of sellers, as 1134 stocks declined on NSE against 509 advancing stocks, while 75 remained unchanged. Similarly, 1608 stocks were declining on BS against 936 adavcing stocks, while 143 remained unchanged.


PTI
May 20, 2019



BusinessToday.In
New Delhi, May 20, 2019
BSE Sensex is up 1445.67 points or 3.81 per cent at 39,376.44 and NSE Nifty is trading up by 420.70 or 3.69 per cent at 11,827.85, in the last hour of trade.


Reuters
New Delhi, May 19, 2019
Two sources familiar with J&J's operations in India and one state government official told production at the plant, at Penjerla in Telangana, never began because of a slowing in the growth in demand for the products


BusinessToday.In
May 18, 2019
Experts said markets overcame global jitters due to US-China trade war and turned their focus on the Lok Sabha election 2019.


PB Jayakumar
May 17, 2019
Despite the pressure of business in the US, pharma major Lupin Limited recorded a 5.2 per cent rise in revenues to Rs 16,369.4 crore in FY19


E Kumar Sharma
New Delhi, May 16, 2019
Some of the generic companies, it points out, made unsolicited bids to customers of bigger players in cases where drug prices were high as a way to compete with a bigger generic player to grab a bigger share in the market. Interestingly, this exercise seems to have elements of attempts at trying to drive down prices to gain customers.


PB Jayakumar
New Delhi, May 15, 2019
In 2018, India has the largest number of US regulator approved pharmaceutical plants outside the US.


BusinessToday.In
New Delhi, May 15, 2019
After Cognizant, IBM India fires 300 employees from services divisionTech behemoth IBM India has reportedly fired nearly 300 employees from its services division as it looks to \"re-invent\" its operations and fulfill the changing demand of the customers. The US-based IT major let these employees go as it focuses on emerging technology like Artificial Intelligence and reduces exposure to traditional services. US pharma scandal: Indian firm Glenmark may face a penalty of up to $873 millio...


PTI
May 15, 2019
After surging over 200 points in early session, the 30-share index was trading 98.07 points, or 0.26 per cent, higher at 37,416.60. The broader NSE Nifty was also trading 21.65 points, or 0.19 per cent, up at 11,243.70.


BusinessToday.In
May 15, 2019
Share Market Updates: Shedding gains of the trading session Wednesday, benchmark indices closed in the red. Other major indices gave up all intraday gains to turn negative in trade as well.


PTI
May 14, 2019
In separate clarifications to stock exchanges, the companies denied the accusations and stated they would defend themselves in the matter


PTI
May 14, 2019



Mudit Kapoor
May 14, 2019
Severe penalties could be levied on the Indian pharma companies varying from $13 million to $873 million; Glenmark could face the highest penalty, while Aurobindo the least.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 14, 2019
Markets Live: While Sensex is trading 263 points higher at 37,354, Nifty is up 83 points to 11,231.70. Sun Pharma, Vedanta and ICICI Bank were the top gainers on Sensex. Tata Steel, Bajaj Auto and Asian Paints were the top losers on Sensex.


PTI
New Delhi, May 13, 2019
The index shed 1,940.73 points during the trading days from April 26 to May 13


PTI
May 13, 2019



PTI
May 13, 2019



BusinessToday.In
May 13, 2019
Markets Live: Sensex closes 372 points or 0.99 per cent lower at 37,090 and Nifty ended at 11,148 down 130.70 points or 1.16 per cent.


PAGES 1 OF 36  12345